Amgen JAPAC: The Cost of Silence

Amgen, a global bio-pharmaceutical company, made strides to change policies regarding the older population in Hong Kong.

The Challenge

Amgen, a global bio-pharmaceutical company, operates to promote healthy ageing and improve the lives of those who suffer from serious diseases. The world’s population of people over 60 is growing; already nearing 1bn. United Nations predicts that by 2050 this figure will reach 2.1bn, with around half of these living in Asia. In such an environment, one of the biggest challenges for Amgen is to create awareness of some of the leading diseases in Asia. There are two focus areas: Cardiovascular disease (CVD) and Osteoporosis (OP). CVD is the leading cause of death in the world, and one...

Not a subscriber?

Schedule your live demo with our team today

WARC helps you to plan, create and deliver more effective marketing

  • Prove your case and back-up your idea

  • Get expert guidance on strategic challenges

  • Tackle current and emerging marketing themes

We’re long-term subscribers to WARC and it’s a tool we use extensively. We use it to source case studies and best practice for the purposes of internal training, as well as for putting persuasive cases to clients. In compiling a recent case for long-term, sustained investment in brand, we were able to support key marketing principles with numerous case studies sourced from WARC. It helped bring what could have been a relatively dry deck to life with recognisable brand successes from across a broad number of categories. It’s incredibly efficient to have such a wealth of insight in one place.

Insights Team
Bray Leino

You’re in good company

We work with 80% of Forbes' most valuable brands* and 80% of the world's top top-of-the-class agencies.

* Top 10 brands